13 studies found for:    11784875 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: MK-3475;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pemetrexed
2 Recruiting Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer
Condition: Non-small-cell Lung Cancer
Interventions: Drug: Nimotuzumab;   Drug: docetaxel and cisplatin;   Radiation: daily RT (65Gy in 25 fractions) to the chest;   Drug: placebo
3 Not yet recruiting A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Carcinoma of the Lung.
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin
4 Recruiting Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Lenalidomide
5 Recruiting Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy
Condition: Squamous Cell Lung Cancer
Interventions: Drug: Boanmycin;   Drug: Docetaxel
6 Recruiting Biomarker Discovery and Validation in Lung Cancer
Condition: Lung Cancer
Intervention: Procedure: Collection of biospecimen
7 Completed
Has Results
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
Conditions: NSCLC;   Solid Tumors
Interventions: Drug: YM155;   Drug: Carboplatin;   Drug: Paclitaxel
8 Unknown  Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: sunitinib, docetaxel, cisplatin
9 Active, not recruiting Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small-Cell Lung
10 Completed
Has Results
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: FDG-PET;   Drug: Pemetrexed;   Drug: Sirolimus;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic acid tablets;   Drug: Dexamethasone tablets
11 Unknown  Tarceva Italian Lung Optimization tRial
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Erlotinib;   Drug: Docetaxel
12 Unknown  Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Procedure: FDG-/FLT-PET
13 Completed
Has Results
BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
Intervention: Drug: BAY 43-9006 (Sorafenib)

Indicates status has not been verified in more than two years